Issue

Vol. 29 No. 5 (2017): Vol 29 Issue 5

Copyright (c) 2017 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Synergistic Effect of Quercetin Nanoparticles on Liver and Pancreas Tissues and Oxidative Stress of Streptozotocin-Induced Diabetic Rats

https://doi.org/10.14233/ajchem.2017.20389
Soheir N. Abd El-Rahman
Department of Chemistry, College of Science, University of Dammam, Dammam, Saudi Arabia; Agriculture Research Center, Giza, Egypt
Suhailah S. Al-Jameel
Department of Chemistry, College of Science, University of Dammam, Dammam, Saudi Arabia

Corresponding Author(s) : Soheir N. Abd El-Rahman

soheirkenawy@yahoo.com

Asian Journal of Chemistry, Vol. 29 No. 5 (2017): Vol 29 Issue 5

Abstract

Nanotechnology technique increases the solubility in water and bioavailability of drug. This study aimed to investigate the synergistic effects of quercetin nanoparticales (QUNPs) on a streptozotocin (STZ)-induced diabetic rats to determine their potential role in alleviating diabetes and its oxidative stress-induced. In this study, STZ-diabetic rats were treated with QUNPs (10 and 20 mg/kg bw/day) for 7 weeks to analyze their effects on lipid profile, markers of hepatic enzyme and enzymic antioxidant (MDA, SOD, GSH), also pancreas and liver tissues. The results of this study indicated that QUNPs (10 and 20 mg/kg bw/day) administrated rats down-modify hyperglycemia and oxidative stress. Furthermore, when treated diabetic rats with QUNPs (10 and 20 mg/kgbw/day) it is noticed a high significant improvement in histological structural degeneration of pancreas and liver. Quercetin nanoparticales (20 mg/kg bw/day) exhibited maximum inhibition of lipid profile, hepatic enzymes and oxidative stress, which indicates a protective role in the diabetic rats pancreas and liver. Present results show that the quercetin nanoparticles synergistic effects to improve hyperglycemia and oxidative stress in diabetic rats and so, open a new areas that can help to define a different trend on the developing of active treatments of nano-flavonoids.

Keywords

Quercetin nanoparticles Diabetic rats Streptozotocin Free radicals Antioxidant Oxidative stress
Abd El-Rahman, S. N., & Al-Jameel, S. S. (2017). Synergistic Effect of Quercetin Nanoparticles on Liver and Pancreas Tissues and Oxidative Stress of Streptozotocin-Induced Diabetic Rats. Asian Journal of Chemistry, 29(5), 1003–1010. https://doi.org/10.14233/ajchem.2017.20389
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. V. Sharma, K. Samanta and Pooja, J. Appl. Pharm. Sci., 1, 106 (2011).
  2. D.D. de Silva, S. Rapior, K.D. Hyde and A.H. Bahkali, Fungal Divers., 56, 1 (2012); https://doi.org/10.1007/s13225-012-0187-4.
  3. C.B. Renard, F. Kramer, F. Johansson, N. Lamharzi, L.R. Tannock, M.G. Herrath, A. Chait and K.E. Bornfeldt, J. Clin. Invest., 114, 659 (2004); https://doi.org/10.1172/JCI200417867.
  4. A.K. Mohamed, A. Bierhaus, S. Schiekofer, H. Tritschler, R. Ziegler and P.P. Nawroth, Biofactors, 10, 157 (1999); https://doi.org/10.1002/biof.5520100211.
  5. T. Szkudelski, Physiol. Res, 50, 536 (2001).
  6. M. Kanter, O. Coskun, A. Korkmaz and S. Oter, Anat. Rec. A Discov. Mol. Cell Evol. Biol., 279, 685 (2004).
  7. J.W. Baynes and S.R. Thorpe, Curr. Opin. Endocrinol. Diab., 3, 277 (1996).
  8. K. Stadler, V. Jenei, G. von Bölcshazy, A. Somogyi and J. Jakus, Free Radic. Biol. Med., 35, 1240 (2003); https://doi.org/10.1016/S0891-5849(03)00499-4.
  9. A. Seven, S. Güzel, O. Seymen, S. Civelek, M. Bolayirli, M. Uncu and G. Burcak, Yonsei Med. J., 45, 703 (2004); https://doi.org/10.3349/ymj.2004.45.4.703.
  10. R.A. Kowluru and P. Koppolu, Free Radic. Res., 36, 993 (2002); https://doi.org/10.1080/1071576021000006572.
  11. R.A. Kowluru and P.-S. Cha, Exp. Diabetes Res., Article ID 43603 (2007); https://doi.org/10.1155/2007/43603.
  12. T. Karaca, M. Cemek and M. Kanter, Acta Vet. Brno, 75, 33 (2006); https://doi.org/10.2754/avb200675010033.
  13. P. K. Knekt, J. umpulainen, R. Järvinen, H. Rissanen, M. R. Heliövaara, A. Eunanen, T. Hakulinen and A. Aromaa, Am. J. Clin. Nutr., 76, 560 (2002).
  14. L. Bláha, R. Kopp, K. Simkova and J. Mares, Acta Vet. Brno, 73, 477 (2004); https://doi.org/10.2754/avb200473040477.
  15. A.S. Dias, M. Porawski, M. Alonso, N. Marroni, P.S. Collado and J. González-Gallego, J. Nutr., 135, 2299 (2005).
  16. W. Chen, S. Sun, W. cao, Y. Liang and J. Song, J. Mol. Struct., 918, 194 (2009); https://doi.org/10.1016/j.molstruc.2008.08.008.
  17. S. Baghel, N. Shrivastava and S. Baghel, World J. Pharm. Pharm. Sci., 1, 146 (2012).
  18. S.N. Abd El-Rahmanand and S.S. Al-Jameel, Indian J. Drugs, 2, 96 (2014).
  19. C. Kanadaswami, L.T. Lee, P.P. Lee, J.J.F.C. Hwang, Y.T. Huang and M.T. Lee, In Vivo, 19, 895 (2005).
  20. M. Comalada, D. Camuesco, S. Sierra, I. Ballester, J. Xaus, J. Gálvez and A. Zarzuelo, Eur. J. Immunol., 35, 584 (2005); https://doi.org/10.1002/eji.200425778.
  21. M.E. Inal and A. Kahraman, Toxicology, 154, 21 (2000); https://doi.org/10.1016/S0300-483X(00)00268-7.
  22. E.-S. Lee, H.-E. Lee, J.-Y. Shin, S. Yoon and J.-O. Moon, J. Pharm. Pharmacol., 55, 1169 (2003); https://doi.org/10.1211/0022357021396.
  23. O. Coskun, M. Kanter, A. Korkmaz and S. Oter, Pharmacol. Res., 51, 117 (2005); https://doi.org/10.1016/j.phrs.2004.06.002.
  24. A. Yokoyama, A. Yokoyama, H. Sakakibara, A. Yokoyama, H. Sakakibara, A. Crozier, Y. Kawai, A. Matsui, J. Terao, S. Kumazawa and K. Shimoi, Free Radic. Res., 43, 913 (2009); https://doi.org/10.1080/10715760903137010.
  25. M.I. Yousef, S.A.M. Omar, M.I. El-Guendi and L.A. Abdelmegid, Food Chem. Toxicol., 48, 3246 (2010); https://doi.org/10.1016/j.fct.2010.08.034.
  26. P.J. Mulholland, D.R. Ferry, D. Anderson, S.A. Hussain, A.M. Young, J.E. Cook, E. Hodgkin, L.W. Seymour and D.J. Kerr, Ann. Oncol., 12, 245 (2001); https://doi.org/10.1023/A:1008372017097.
  27. U. Bilati, E. Allémann and E. Doelker, Eur. J. Pharm. Sci., 24, 67 (2005); https://doi.org/10.1016/j.ejps.2004.09.011.
  28. I. Bala, V. Bhardwaj, S. Hariharan, S.V. Kharade, N. Roy and M.N.V. Ravi Kumar, J. Drug Target., 14, 27 (2006); https://doi.org/10.1080/10611860600565987.
  29. C.-H. Hsu, Z. Cui, R.J. Mumper and M. Jay, AAPS Pharm. Sci. Tech., 4, 24 (2003); https://doi.org/10.1208/pt040332.
  30. M.E. Matteucci, M.A. Hotze, K.P. Johnston and R.O. Williams, Langmuir, 22, 8951 (2006); https://doi.org/10.1021/la061122t.
  31. M. Kakran, N.G. Sahoo, L. Li and Z. Judeh, Powder Technol., 223, 59 (2012); https://doi.org/10.1016/j.powtec.2011.08.021.
  32. S. Schermer, The Blood Morphology of Laboratory Animal, Longman Green and Co. Ltd., pp. 350 (1967).
  33. S. Reitman and S. Frankel, Am. J. Clin. Pathol., 28, 56 (1957); https://doi.org/10.1093/ajcp/28.1.56.
  34. N. Ohkuma, S. Matsuo, M. Tutsui, and A. Ohkawara, Nippon Hifuka Gakkai Zasshi, 92, 583 (1982).
  35. G.L. Ellman, Arch. Biochem. Biophys., 82, 70 (1959); https://doi.org/10.1016/0003-9861(59)90090-6.
  36. M. Reinboth, S. Wolffram, G. Abraham, F.R. Ungemach and R. Cermak, Br. J. Nutr., 104, 198 (2010); https://doi.org/10.1017/S000711451000053X.
  37. D. Chitkara, S.K. Nikalaje, A. Mittal, M. Chand and N. Kumar, Drug Deliv. Translat. Res., 2, 112 (2012); https://doi.org/10.1007/s13346-012-0063-5.
  38. K. Yin Win and S.-S. Feng, Biomaterials, 26, 2713 (2005); https://doi.org/10.1016/j.biomaterials.2004.07.050.
  39. M. Kakran, R. Shegokar, N.G. Sahoo, L. Al Shaal, L. Li and R.H. Müller, Eur. J. Pharm. Biopharm., 80, 113 (2012); https://doi.org/10.1016/j.ejpb.2011.08.006.
  40. C. Keck and R. Muller, Eur. J. Pharm. Biopharm., 62, 3 (2006); https://doi.org/10.1016/j.ejpb.2005.05.009.
  41. N. Hamadi, A. Mansour, M.H. Hassan, F. Khalifi-Touhami and O. Badary, J. Biochem. Mol. Toxicol., 26, 384 (2012); https://doi.org/10.1002/jbt.21432.
  42. H. Elbe, M. Esrefoglu, N. Vardi, E. Taslidere, E. Ozerol and K. Tanbek, Hum. Exp. Toxicol., 34, 859 (2015); https://doi.org/10.1177/0960327114559993.
  43. A. Arya, C. Yeng Looi, S. Chuen Cheah, M. Rais Mustafa and M. Ali Mohd, J. Ethnopharmacol., 144, 22 (2012); https://doi.org/10.1016/j.jep.2012.08.014.
  44. H. Taha, A. Arya, M. Paydar, C.Y. Looi, W.F. Wong, C.R. Vasudeva Murthy, M.I. Noordin, H.M. Ali, A.M. Mustafa and A.H.A. Hadi, Food Chem. Toxicol., 66, 295 (2014); https://doi.org/10.1016/j.fct.2014.01.054.
  45. B.K. McNab, Biochem. Physiol. C: Toxicol. Pharmacol., 135, 357 (2003); https://doi.org/10.1016/S1095-6433(03)00090-4.
  46. P. Palsamy and S. Subramanian, Biomed. Pharmacother., 62, 598 (2008); https://doi.org/10.1016/j.biopha.2008.06.037.
  47. W. Wang, C. Wang, X.-Q. Ding, Y. Pan, T.-T. Gu, M.-X. Wang, Y.-L. Liu, F.-M. Wang, S.-J. Wang and L.-D. Kong, Br. J. Pharmacol., 169, 1352 (2013); https://doi.org/10.1111/bph.12226.
  48. M. Kobori, S. Masumoto, Y. Akimoto and Y. Takahashi, Mol. Nutr. Food Res., 53, 859 (2009); https://doi.org/10.1002/mnfr.200800310.
  49. I. N. Nuraliev and G. A. Avezov, Eksp. Klin. Farmakol., 55, 42 (1992).
  50. A. Arya, M.M. Jamil Al-Obaidi, N. Shahid, M.I. Bin Noordin, C.Y. Looi, W.F. Wong, S.L. Khaing and M.R. Mustafa, Food Chem. Toxicol., 71, 183 (2014); https://doi.org/10.1016/j.fct.2014.06.010.
  51. P.S.M. Prince and N. Kamalakkannan, J. Biochem. Mol. Toxicol., 20, 96 (2006); https://doi.org/10.1002/jbt.20117.
  52. R.M. Maciel, M.M. Costa, D.B. Martins, R.T. França, R. Schmatz, D.L. Graça, M.M.M.F. Duarte, C.C. Danesi, C.M. Mazzanti, M.R.C. Schetinger, F.C. Paim, H.E. Palma, F.H. Abdala, N. Stefanello, C.K. Zimpel, D.V. Felin and S.T.A. Lopes, Res. Vet. Sci., 95, 389 (2013); https://doi.org/10.1016/j.rvsc.2013.04.028.
  53. J.M. Cullen, in eds.: M.D. McGavin and J.F. Zachary, Fígado, Sistema Biliar e Pâncreas Exócrino, Elsevier Editoral tda, Rio de Janeiro, Brazil, pp. 393–461 (2009).
  54. R.W. Nelson, in eds.: C.T. Moonney and M.E. Peterson, Diabetes Melito canina, Editora Roca, São Paulo, Brazil, pp. 137–156 (2009).
  55. 57 N. Hamadi, A. Mansour, M.H. Hassan, F. Khalifi-Touhami and O. Badary, J. Biochem. Mol. Toxicol., 26, 384 (2012); https://doi.org/10.1002/jbt.21432.
  56. A.A. Abolfathi, D. Mohajeri, A. Rezaie and M. Nazeri, Evid. Based Complem. Alternat. Med., Article ID 740671 (2012); https://doi.org/10.1155/2012/740671.
  57. M. Ferrali, C. Signorini, B. Caciotti, L. Sugherini, L. Ciccoli, D. Giachetti and M. Comporti, FEBS Lett., 416, 123 (1997); https://doi.org/10.1016/S0014-5793(97)01182-4.
  58. A.J. Elliott, S.A. Scheiber, C. Thomas and R.S. Pardini, Biochem. Pharmacol., 44, 1603 (1992); https://doi.org/10.1016/0006-2952(92)90478-2.
  59. A.V. Kozlov, E.A. Ostrachovitch and I.B. Afanas’ev, Biochem. Pharmacol., 47, 795 (1994).https://doi.org/10.1016/0006-2952(94)90479-0.
  60. T.S. Devi, I. Lee, M. Huttemann, A. Kumar, K.D. Nantwi and L.P. Singh, Exp. Diabetes Res., Article ID 438238 (2012); https://doi.org/10.1155/2012/438238.
  61. R. Babujanarthanam, P. Kavitha, U.S. Mahadeva Rao and M.R. Pandian, Mol. Cell. Biochem., 358, 121 (2011); https://doi.org/10.1007/s11010-011-0927-x.
  62. A. Gumieniczek, Diabetes Res. Clin. Pract., 68, 89 (2005); https://doi.org/10.1016/j.diabres.2004.09.018.
  63. P. Yadav, S. Sarkar and D. Bhatnagar, Pharmacol. Res., 36, 221 (1997); https://doi.org/10.1006/phrs.1997.0222.
  64. H.R. Yilmaz, E. Uz, N. Yucel, I. Altuntas and N. Ozcelik, J. Biochem. Mol. Toxicol., 18, 234 (2004); https://doi.org/10.1002/jbt.20028.
  65. A.A. Atef and M.K. Ezz, J. Appl. Sci. Res., 8, 1576 (2012).
  66. D. Sirovina, N. Orsolic, M.Z. Koncic, G. Kovacevic, V. Benkovic and G. Gregorovic, Human Exp. Toxicol., 32, 1058 (2013); https://doi.org/10.1177/0960327112472993.
  67. K. Tatsuki, K. Satoh, A. Yamamoto, K. Hoshi and K. Ichihara, Jpn. J. Pharmacol., 75, 267 (1997); https://doi.org/10.1254/jjp.75.267.
  68. A. Machha, F.I. Achike, A.M. Mustafa and M.R. Mustafa, Nitric Oxide, 16, 442 (2007); https://doi.org/10.1016/j.niox.2007.04.001.
  69. M. Motshakeri, M. Ebrahimi, Y.M. Goh, H.H. Othman, M. Hair-Bejo and S. Mohamed, Evid. Based Compl. Alternat. Med., Article ID 379407 (2014); https://doi.org/10.1155/2014/379407.
  70. J.Y. Zhou, S.W. Zhou, K.B. Zhang, J.L. Tang, L.X. Guang, Y. Ying, Y. Xu, L. Zhang and D.D. Li, Biol. Pharm. Bull., 31, 1169 (2008); https://doi.org/10.1248/bpb.31.1169.
  71. E.Taslidere, N.Vardi, D.Orman and H. Elbe, J. Turgut Ozal Med. Cent., 21, 111 (2014).
  72. R. Yanardag, O. Ozsoy-Sacan, S. Bolkent, H. Orak and O. Karabulut- Bulan, Hum. Exp. Toxicol., 24, 129 (2005); https://doi.org/10.1191/0960327104ht507oa.
  73. M. Zafar, S.N. Naqvi, M. Ahmed and Z. A. Kaimkhani, Int. J. Morphol., 27, 719 (2009); https://doi.org/10.4067/S0717-95022009000300015.
  74. N. Kandasamy and N. Ashokkumar, Biomed. Prev. Nutr., 2, 246 (2012); https://doi.org/10.1016/j.bionut.2012.04.003.
  75. R. Roat, V. Rao, N.M. Doliba, F.M. Matschinsky, J.W. Tobias, E. Garcia, R.S. Ahima and Y. Imai, PLoS One, 9, e86815 (2014); https://doi.org/10.1371/journal.pone.0086815.
  76. R.A. Rifaai, N.F. El-Tahawy, E.A. Saber and R. Ahmed, J. Diabetes Metab., 3, 182 (2012); https://doi.org/10.4172/2155-6156.1000182.
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 0